Event-free survival as a predictor of overall survival and recurrence burden of patients with non –small cell lung cancer receiving neoadjuvant therapy

This study aims to examine the correlation between real-world event-free survival and overall survival and to assess the clinical and economic burden associated with disease recurrence among patients with resected stage II to III non –small cell lung cancer who received neoadjuvant therapy in the United States.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Thoracic Source Type: research